MARKET

MBII

MBII

MARRONE BIO INNO
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.8789
+0.0329
+3.89%
After Hours: 0.8700 -0.0089 -1.01% 17:13 09/17 EDT
OPEN
0.8423
PREV CLOSE
0.8460
HIGH
0.8943
LOW
0.8128
VOLUME
1.61M
TURNOVER
--
52 WEEK HIGH
2.900
52 WEEK LOW
0.7684
MARKET CAP
154.94M
P/E (TTM)
-8.4428
1D
5D
1M
3M
1Y
5Y
Looking At The Main Cannabis Stocks Movers For Friday Sept. 10
GAINERS: Greenlane Hldgs (NASDAQ:GNLN) shares closed up 18.43% at $3.02 with an estimated market cap of $228.8M.
Benzinga · 5d ago
Marrone Bio Innovations Readies Regulatory Submissions for New Pesticides in US, Brazil
MT Newswires · 09/09 13:06
Marrone Bio Prepares To Submit Registration For Next-Generation Crop Protection Product In North America
 Marrone Bio Innovations, Inc. (NASDAQ:MBII), an international leader in sustainable bioprotection and plant health solutions, is on track to submit MBI-306, its next generation nematicide/insecticide, to
Benzinga · 09/09 12:17
Marrone Bio Prepares to Submit Registration for Next-Generation Crop Protection Product in North America
Company Also Looks to Expand Footprint in South America with Regulatory Submission of Bionematicide Seed Treatment, MBI-206, in BrazilDAVIS, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in...
GlobeNewswire · 09/09 12:00
Monday's Marijuana Stock Movers
GAINERS: Rhinomed (OTC:RHNMF) shares closed up 10.77% at $0.29 with an estimated market cap of $73.9M.
Benzinga · 08/30 22:58
Cannabis Stocks: Today's Gainers and Losers
GAINERS: Item 9 Labs (OTC:INLB) shares closed up 13.64% at $2.5 with an estimated market cap of $230,523,802.
Benzinga · 08/30 22:52
The Consensus EPS Estimates For Marrone Bio Innovations, Inc. (NASDAQ:MBII) Just Fell Dramatically
One thing we could say about the analysts on Marrone Bio Innovations, Inc. ( NASDAQ:MBII ) - they aren't optimistic...
Simply Wall St. · 08/22 12:50
Aegis Capital Maintains Buy on Marrone Bio Innovations, Lowers Price Target to $2.5
Aegis Capital analyst Nathan Weinstein maintains Marrone Bio Innovations (NASDAQ:MBII) with a Buy and lowers the price target from $3.5 to $2.5.
Benzinga · 08/19 13:35
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MBII. Analyze the recent business situations of MARRONE BIO INNO through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average MBII stock price target is 2.630 with a high estimate of 4.000 and a low estimate of 1.650.
EPS
Institutional Holdings
Institutions: 92
Institutional Holdings: 93.88M
% Owned: 53.25%
Shares Outstanding: 176.28M
TypeInstitutionsShares
Increased
32
3.23M
New
9
20.63M
Decreased
15
783.42K
Sold Out
9
247.01K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Agricultural Chemicals
-0.30%
Chemicals
-1.53%
Key Executives
Non-Executive Chairman/Independent Director
Robert Woods
Chief Executive Officer/Director
Kevin Helash
Chief Financial Officer
Suping Liu Cheung
Executive Vice President/Chief Compliance Officer/General Counsel/Secretary
Linda Moore
Senior Vice President/Chief Technology Officer
Amit Vasavada
Senior Vice President
Keith Pitts
Senior Vice President
Matti Tiainen
Vice President
Timothy Johnson
Director
Pamela Marrone
Independent Director
Lara Lee
Independent Director
Yogesh Mago
Independent Director
Keith McGovern
Independent Director
Zachary Wochok
Independent Director
Stuart Woolf
No Data
About MBII
Marrone Bio Innovations, Inc. offers bio-based pest management and plant health products. The Company's bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene. Its products are used in both conventional and organic crop production, and are sold to growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens and ornamental plants. It offers Regalia for large-acre row crops, such as corn and soybeans. Its pipeline of early-stage discoveries and product candidates extends across a range of product types for end markets, including herbicides, fungicides, nematicides, insecticides, algaecides (for algae control), molluscicides (for mussel and snail control), and plant growth and plant stress regulators. It is engaged in developing MBI-010, MBI-110, Haven (MBI-505) and MBI-601.

Webull offers kinds of Marrone Bio Innovations Inc stock information, including NASDAQ:MBII real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MBII stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MBII stock methods without spending real money on the virtual paper trading platform.